The analysis of forecasted Business Enterprise R&D Expenditure in the US for the manufacture of irradiation, electromedical, and electrotherapeutic equipment indicates a consistent decline over the next few years. Starting from $2.21 billion in 2024, the expenditure is expected to decrease to $1.32 billion by 2028. In 2023, the expenditure stood at the highest level of $2.44 billion. Year-on-year variations show a shift towards reduced spending, with a compound annual growth rate indicating a notable downtrend.
Future trends to watch include technological advancements that might revitalize interest and investment in R&D, regulatory changes affecting the equipment market, and potential demand shifts due to an aging population and increased focus on healthcare innovations.
